News

Hikma Pharmaceuticals USA Inc.: Hikma acquires Novugen's FDA-approved ANDA for trametinib
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces it has acquired the FDA-approved ...
Hikma acquires rights to generic version of Novartis' Mekinist
Hikma buys rights to FDA-approved cancer treatment trametinib, a generic version of Novartis' (NVS) Mekinist, with 180 days ...
Le Lézard1d
Canadian Investment Regulatory Organization Trade Resumption - FYL
Finlay Minerals Ltd. TSX-Venture Symbol: FYL All Issues: Yes Resumption (ET): 1:30 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed ...
Hikma acquires Novugen's FDA-approved ANDA for trametinib
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces it has acquired the FDA-approved Abbreviated New Drug Application (ANDA) for trametinib tablets from ...
Pharmaceuticals are the next Trump tariff battleground - what will they mean for the NHS?
UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...
Conventus Law2d
US – Hikma And Amici Curiae Ask Supreme Court To Revisit Induced Infringement by Generic “Skinny Labels”.
US - Hikma And Amici Curiae Ask Supreme Court To Revisit Induced Infringement by Generic “Skinny Labels”. Legal News and ...
With 57% ownership, Hikma Pharmaceuticals PLC (LON:HIK) boasts of strong institutional backing
Given the large stake in the stock by institutions, Hikma Pharmaceuticals' stock price might be vulnerable to their trading decisions. A total of 12 investors have a ...